We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$6.7B
AUM Growth
+$1.02B
Cap. Flow
+$770M
Cap. Flow %
11.48%
Top 10 Hldgs %
25.88%
Holding
1,284
New
122
Increased
619
Reduced
280
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Financials 5.76%
3 Healthcare 4.66%
4 Consumer Discretionary 4.38%
5 Industrials 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHQ icon
626
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$350K 0.01%
5,209
GLW icon
627
Corning
GLW
$119B
$347K 0.01%
7,696
+1,115
+17% +$46.9K
DFAX icon
628
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.9B
$343K 0.01%
+12,695
New +$329K
LEN icon
629
Lennar Class A
LEN
$19.8B
$342K 0.01%
1,884
+293
+18% +$49.1K
TDIV icon
630
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.18B
$341K 0.01%
4,251
+1
+0% +$77
DTE icon
631
DTE Energy
DTE
$29.5B
$341K 0.01%
2,657
+25
+0.9% +$3.01K
MKL icon
632
Markel Group
MKL
$23.3B
$339K 0.01%
216
+16
+8% +$25K
ACWI icon
633
iShares MSCI ACWI ETF
ACWI
$32.9B
$337K 0.01%
2,815
+2,754
+4,515% +$316K
VRSK icon
634
Verisk Analytics
VRSK
$25.4B
$334K 0.01%
1,245
+97
+8% +$26.3K
DG icon
635
Dollar General
DG
$28B
$333K 0.01%
3,932
+22
+0.6% +$2.41K
DGRW icon
636
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
$332K ﹤0.01%
3,987
+481
+14% +$38.5K
XSEP icon
637
FT Vest US Equity Enhance & Moderate Buffer ETF September
XSEP
$135M
$330K ﹤0.01%
8,600
HLT icon
638
Hilton Worldwide
HLT
$72.1B
$329K ﹤0.01%
1,429
+39
+3% +$8.44K
REGL icon
639
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.75B
$328K ﹤0.01%
4,010
+29
+0.7% +$2.28K
PPG icon
640
PPG Industries
PPG
$24.6B
$326K ﹤0.01%
+2,463
New +$311K
KR icon
641
Kroger
KR
$35.4B
$325K ﹤0.01%
5,665
+667
+13% +$35.8K
MDY icon
642
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$324K ﹤0.01%
569
-23
-4% -$12.7K
GSK icon
643
GSK
GSK
$104B
$322K ﹤0.01%
7,886
+2,365
+43% +$96.8K
STZ icon
644
Constellation Brands
STZ
$22.2B
$321K ﹤0.01%
1,247
+26
+2% +$6.45K
IRM icon
645
Iron Mountain
IRM
$36.4B
$320K ﹤0.01%
2,693
-7
-0.3% -$749
KHC icon
646
Kraft Heinz
KHC
$30.7B
$320K ﹤0.01%
9,112
-785
-8% -$27K
IDXX icon
647
Idexx Laboratories
IDXX
$44.1B
$318K ﹤0.01%
629
+102
+19% +$49.6K
LRGF icon
648
iShares US Equity Factor ETF
LRGF
$3.58B
$317K ﹤0.01%
5,401
+2,003
+59% +$113K
VXF icon
649
Vanguard Extended Market ETF
VXF
$30.3B
$317K ﹤0.01%
1,741
+999
+135% +$175K
MLM icon
650
Martin Marietta Materials
MLM
$31.5B
$314K ﹤0.01%
583
+36
+7% +$19.5K

Similar funds

Aptus Capital Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Aptus Capital Advisors held 1,284 positions worth $6.7B, up 18% from $5.68B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Aptus Capital Advisors deployed $770M of net new capital in Q3 2024, opening 122 new positions and adding to 619 existing holdings. Its largest new stake was Fidelity Total Bond ETF: 871,158 shares worth $40.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Pharmaceuticals ETF, an estimated $12.8M trimmed.

  • Aptus Capital Advisors's largest Q3 2024 buy was Fidelity Total Bond ETF: 871,158 shares worth $40.7M.
  • Aptus Capital Advisors added most to Aptus Collared Investment Opportunity ETF in Q3 2024, an estimated $50.4M increase.
  • Aptus Capital Advisors's biggest Q3 2024 reduction was iShares US Pharmaceuticals ETF, cutting an estimated $12.8M.
  • Aptus Capital Advisors fully exited Valvoline in Q3 2024, selling an estimated $7.76M.
  • Aptus Capital Advisors's ten largest holdings make up 26% of its $6.7B portfolio in Q3 2024.
  • Aptus Capital Advisors opened 122 new positions and closed 52 in Q3 2024.
  • Aptus Capital Advisors's portfolio value rose 18% quarter-over-quarter to $6.7B.

Based on Aptus Capital Advisors's 13F filing for Q3 2024, filed 5 Nov 2024.